No. 1-ranked men’s tennis player Jannik Sinner will be playing in the U.S. Open, which begins next week in New York, even though word just emerged that he tested positive twice in March for a banned anabolic steroid.
It’s a case that no one knew about until Tuesday and one that has drawn all sorts of questions—and, in some instances, criticism. Other players wonder whether there was a double standard at play because of Sinner’s success, are confused about why this was all kept under wraps, and want to know why Sinner was allowed to keep competing before there was a resolution.
